BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32154466)

  • 1. Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs.
    Moss LI; Tompkins VS; Moss WN
    Noncoding RNA Res; 2020 Mar; 5(1):32-36. PubMed ID: 32154466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
    Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
    PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NcRNA-microchip analysis: a novel approach to identify differential expression of noncoding RNAs.
    Hutzinger R; Mrázek J; Vorwerk S; Hüttenhofer A
    RNA Biol; 2010; 7(5):586-95. PubMed ID: 21037422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
    Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
    BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic and structural characterization of an EBV infected B-cell lymphoma transcriptome.
    O'Leary CA; Van Tompkins S; Rouse WB; Nam G; Moss WN
    NAR Genom Bioinform; 2022 Dec; 4(4):lqac082. PubMed ID: 36285286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV.
    Sugamura K; Tanaka Y; Hinuma Y
    Microbiol Immunol; 1982; 26(7):575-83. PubMed ID: 6290853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
    Lacy J; Summers WP; Watson M; Glazer PM; Summers WC
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes.
    Assadian F; Kamel W; Laurell G; Svensson C; Punga T; Akusjärvi G
    PLoS One; 2017; 12(5):e0177275. PubMed ID: 28542273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis.
    Iwakiri D
    Virus Res; 2016 Jan; 212():30-8. PubMed ID: 26292159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
    Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
    J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.
    Kanamori M; Watanabe S; Honma R; Kuroda M; Imai S; Takada K; Yamamoto N; Nishiyama Y; Kawaguchi Y
    J Virol; 2004 Apr; 78(8):3984-93. PubMed ID: 15047814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.
    Colby BM; Furman PA; Shaw JE; Elion GB; Pagano JS
    J Virol; 1981 May; 38(2):606-11. PubMed ID: 6264131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
    Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
    RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.